Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lung Diseases, Interstitial

• Platform Clinical Study for Conquering Scleroderma
• A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
• Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
• 129Xe MRI Cardiopulmonary
• Rituxmab Versus IL-6 in Treating ILD
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
• Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults
• Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
• Anlotinib Capsules in the Treatment for IPF/PF-ILDs
• Myositis Interstitial Lung Disease Nintedanib Trial
• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
• Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
• Feasibility of Semaglutide in Advanced Lung Disease
• An Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
• Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) or Non-IPF Progressive Pulmonary Fibrosis
• A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
• Efficacy and Immune Function of Pirfenidone in CTD-ILD
• Collagen-targeted PET Imaging for Early Interstitial Lung Disease
• FAPI PET for Lung Fibrosis
• Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease: a Pilot Study
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
• A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD™-ON)
• Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
• Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD)
• Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
• Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
• The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases
• A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
• Phase ll Study of HEC585 in Patients With PF-ILD
• Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells
• Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).
• Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
• Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
• Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease
• A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis
• Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease
• Cost-effectiveness Analysis of Three Corticosteroids in ILDs
• Study of ACE-1334 to Evaluate the Safety, Pharmacokinetics, Pharmacodynamic Effects, and Efficacy in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease
• Immunosuppressant Combined With Pirfenidone in CTD-ILD
• Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
• Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
• A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients
• Pulmonary Hypertension SOLAR
• Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
• Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
• TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
• TOFAcitinib in SARS-CoV2 Pneumonia
• Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
• Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
• Efficacy and Safety of Pirfenidone Treatment in HPS-ILD
• The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
• A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)
• Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
• Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)
• Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease
• Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness
• Hydroxychloroquin (HCQ) in chILD of Genetic Defect
• A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
• Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
• Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease
• CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
• A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
• Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
• A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis.
• Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
• Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
• Basiliximab Treating Interstitial Pneumonia of CADM
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
• A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
• APRIL (AbatacePt in Rheumatoid Arthritis-ILD)
• Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea
• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
• Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases
• Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis
• Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease
• The Coagulation Cascade in Idiopathic Pulmonary Fibrosis
• Hepatitis C Virus(HCV) Heart and Lung Study
• Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
• Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)
• Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
• Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency
• Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
• Abituzumab in SSc-ILD
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
• Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease
• Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD)
• Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
• MSC for Treatment of Interstitial Lung Disease After Allo-HSCT
• Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
• Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
• Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
• Rituximab in Interstitial Pneumonitis
• A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
• Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep
• Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
• Novartis Everolimus Transition
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
• A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
• Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
• Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
• Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
• Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease
• Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease
• A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
• Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
• Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
• Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
• A Clinical Trial for CTD-ILD Treatment
• Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)
• Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
• GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
• A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
• Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients
• Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
• Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
• Rituximab in Rheumatoid Arthritis Lung Disease
• Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
• Fibrosis in Renal Allografts
• BUILD 3: Bosentan Use in Interstitial Lung Disease
• Open-label Study With Bosentan in Interstitial Lung Disease
• DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)